Consolidate Clinical Inputs and Regulatory Signals
Gather all existing literature, preliminary safety data, clinical advisory feedback, and regulatory guidance relevant to the intervention. The founder audits existing assets to identify critical evidence gaps and ethical considerations.
Synthesising existing inputs exposes knowledge gaps and regulatory hurdles before capital is committed to trials. It establishes an evidence baseline that protects the venture against avoidable compliance failures.
Create a comprehensive input matrix summarising existing clinical evidence, advisory board feedback, ethical considerations, and regulatory classifications. Highlight all identified data deficits that require immediate clinical validation.
Five questions an expert would ask when reviewing your output
Use these to challenge assumptions, pressure-test your logic, and check the quality of this action's output in the context of the parent task and wider venture development.
- 1
What strength of clinical evidence currently supports your core scientific mechanism of action?
- 2
Which regulatory classification applies to your solution, and what specific evidence threshold does it mandate?
- 3
How have you incorporated feedback from key opinion leaders and clinical advisors into your study design?
- 4
What ethical approval hurdles will this validation plan require, and what are the realistic timelines?
- 5
Where are the critical gaps in your current data package that would cause an institutional review board to reject your study?